Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Z Liu

Researcher

NCTR

Also affiliated: United States Food and Drug Administration (2013–2026); Center for Devices and Radiological Health (2026); Office of Science (2026); Boehringer Ingelheim (Japan) (2026); Boehringer Ingelheim (Spain) (2026)

Unknown Researcher

1 h-index 4 pubs 86 cited

Research Areas

Biomedical Subjects

  • Humans
  • Drug Design
  • Databases, Factual
  • SARS-CoV-2
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Spike Glycoprotein, Coronavirus
  • Organelles
  • Retinal Pigment Epithelium
  • Drug and Narcotic Control
  • Models, Biological
  • Endpoint Determination
  • Biomedical Research
  • Chemical and Drug Induced Liver Injury
  • Drug-Related Side Effects and Adverse Reactions

Metrics

  • h-index: 1
  • Publications: 4
  • Citations: 86

Selected Publications

  • SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody (2026)
    Journal of Chemical Information and Modeling DOI OpenAlex
  • The Liver Toxicity Knowledge Base: A Systems Approach to a Complex End Point (2013)
    Clinical Pharmacology & Therapeutics 86 citations DOI OpenAlex

View all publications on OpenAlex →